Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Ehlers-Danlos syndromes (EDS) form a heterogeneous group of hereditary connective tissue diseases characterized by joint hyperlaxity, cutaneous hyperelasticity and tissue fragility. EDS type V is characterized by hyperextensible skin but tissue fragility and joint hyperlaxity are mild. This form of EDS is very rare and has been described in only two families so far. Other reported features include congenital heart disease, hernias and short stature. Transmission is X-linked recessive.
Biomarker and diagnostic research for X-linked Ehlers-Danlos syndrome has been reported in the published literature.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for X-linked Ehlers-Danlos syndrome.
56 publications have been identified in PubMed for X-linked Ehlers-Danlos syndrome. Research spans Case Report / Case Series (34%), Basic Science / Preclinical (21%), and Epidemiology / Natural History (21%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 19 | 34% |
Data assembled from 4 of 12 sources · Last updated Sep 19, 2026, 1:14 PM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Common questions about X-linked Ehlers-Danlos syndrome
Laboratory research
12 |
21% |
Disease patterns and progression | 12 | 21% |
Research summaries | 6 | 11% |
Clinical study results | 5 | 9% |
Testing and diagnosis research | 1 | 2% |
New treatment approaches | 1 | 2% |
Wahman JM (2026). [PMID: 41734363](https://pubmed.ncbi.nlm.nih.gov/41734363/). *JMIR formative research*. [Case Report / Case Series]
Tadakawa M (2026). [PMID: 42092737](https://pubmed.ncbi.nlm.nih.gov/42092737/). *J Obstet Gynaecol Res*. [Case Report / Case Series]
Mansoorshahi S (2026). [PMID: 42157492](https://pubmed.ncbi.nlm.nih.gov/42157492/). *HGG Adv*. [Epidemiology / Natural History]
Davidson L (2026). [PMID: 41489686](https://pubmed.ncbi.nlm.nih.gov/41489686/). *Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery*. [Epidemiology / Natural History]
Balagopal AK (2026). [PMID: 42261541](https://pubmed.ncbi.nlm.nih.gov/42261541/). *Cureus*. [Case Report / Case Series]
Nakahara H (2026). [PMID: 42191857](https://pubmed.ncbi.nlm.nih.gov/42191857/). *J Hum Genet*. [Case Report / Case Series]
Rivera Gomez-Barris BM (2026). [PMID: 41546046](https://pubmed.ncbi.nlm.nih.gov/41546046/). *BMC Vet Res*. [Case Report / Case Series]
Elhance A (2026). [PMID: 41616879](https://pubmed.ncbi.nlm.nih.gov/41616879/). *Journal of vascular surgery*. [Case Report / Case Series]
LaFave ER (2026). [PMID: 42107099](https://pubmed.ncbi.nlm.nih.gov/42107099/). *Chembiochem*. [Basic Science / Preclinical]
Rozen TD (2026). [PMID: 41745718](https://pubmed.ncbi.nlm.nih.gov/41745718/). *Neurology international*. [Epidemiology / Natural History]